India, March 14 -- "Sartorius India, a fully owned subsidiary of German-based Sartorius is contributing significantly to the company's growth by recording an average 5-year CAGR of 24 per cent growth for year ending December 2024" said Sibasis Das, Director, Sales, India and South Asia.

Talking to BioSpectrum, Sibasis Das said "During 2021-22 due to COVID-19 we have witnessed significant growth for the company. Our customers mainly from biopharmaceutical industry continued their buying activities during the period. Post COVID the business became flat at just over double-digit growth in the last two years. Most of our customers are in private sector."

Between 2021 and 2022, Sartorius added a new logistics centre and a state-of-the-art ap...